Choose another ingredient

THE INGREDIENT LIBRARY · Entry 195

Cat’s claw

Engraved study of Cat’s claw. Uncaria tomentosa (Willd. ex Schult.) DC.
Uncaria tomentosa (Willd. ex Schult.) DC. · Decorative illustration

At a glance

An Amazonian vine sold mainly as bark extracts. Two Uncaria species share the name.

Key cautions

  • Avoid during pregnancy; breastfeeding safety is not established.
  • Check first with autoimmune disease, before surgery, or with immune-suppressing, blood-thinning or blood-pressure medicines.
Read the full cautions

What’s inside

Oxindole alkaloids and other constituents vary with plant material and extraction; some marketed extracts are deliberately low in these alkaloids.

Uses in brief

  • Longstanding Amazonian medicinal use; human evidence is inconclusive for arthritis or other health purposes.

History, folklore and reported uses

History, folklore and traditional uses

Indigenous Amazonian use predates today’s capsules and standardized extracts. NCCIH records centuries of use against illness, while modern assessments emphasize that the clinical studies remain too limited for a firm therapeutic conclusion.

Traditional, historical and reported uses

  1. Amazonian illness remedies
    Traditional accountWhy this label?

    The claim records Indigenous illness-remedy practice, without validating a modern product or disease indication.

    NCCIH documents longstanding Indigenous use to ward off disease; it does not validate a specific modern product or indication.

  2. Purified extract investigated for arthritis
    Human researchWhy this label?

    A small randomized double-blind patient study investigated a defined purified extract alongside arthritis medicines, rather than retail products generally.

    Mur and colleagues at Innsbruck University Hospital studied a highly purified pentacyclic-chemotype Uncaria tomentosa extract alongside existing rheumatoid-arthritis medication. This small preliminary study does not establish that retail cat’s-claw products are equivalent or effective; medicine interactions and the card’s pregnancy and immune-system cautions still apply.

Only specifically supported historical or culinary uses are included; tradition is not evidence of effectiveness.

Historical-use additions reviewed 2026-10-08

Story sources

Regional reading paths

These sourced notes describe cultivation, trade, food traditions or material history. A regional connection does not claim exclusive origin.

South America

native; Amazonian South America, including Peru

Traditional bark preparations; clinical benefit remains unproven.

Explore this continent

Identity & detailed reference

Identity

Uncaria tomentosa bark is the main commercial material; U. guianensis also shares the name. Unrelated plants called cat’s claw are not substitutes.

Ingredient details, preparation and research

Also known as: Uña de gato

Source plant or material

Uncaria tomentosa bark is the main commercial material; U. guianensis also shares the name. Unrelated plants called cat’s claw are not substitutes.

Plant family / material: Rubiaceae

Forms and route

Dried bark, decoctions, capsules and standardized extracts; species, part and extract standardization matter.

Vitamins and minerals

A medicinal bark preparation is not assigned a nutrient serving; no dependable vitamin/mineral contribution is claimed.

Absorption and preparation

Extracts with different alkaloid profiles are not interchangeable. No established food pairing makes them clinically equivalent.

Traditional and reported uses

  • Longstanding Amazonian medicinal use; human evidence is inconclusive for arthritis or other health purposes.

Contraindications and cautions

  • Avoid during pregnancy; breastfeeding safety is not established.
  • Check first with autoimmune disease, before surgery, or with immune-suppressing, blood-thinning or blood-pressure medicines.

Similar items and how they compare

  • Pau d’arco

    Another tropical American bark preparation.

    It comes from different trees and carries separate toxicity concerns; cultural geography does not make the herbs interchangeable.

Evidence and identity

Most U.S. preparations contain U. tomentosa, but U. guianensis also occurs in commerce. NCCIH finds no conclusive human evidence for any health purpose.

Preparation differences

EMA describes several extracts, including products with different oxindole alkaloid contents and a filtered aqueous preparation nearly free of them. A trial of one product cannot establish equivalence for another.

Safety boundaries

Immune effects may matter in autoimmune disease. Bleeding and medicine interactions are concerns, some theoretical; disclose use before surgery. Pregnancy use may be unsafe.

Evidence limits

  • Common names do not verify species or alkaloid profile.

Entry sources